BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18338811)

  • 1. Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study.
    Gold MA; Tian C; Whitney CW; Rose PG; Lanciano R
    Cancer; 2008 May; 112(9):1954-63. PubMed ID: 18338811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cancer: combined modality therapy.
    Grigsby PW
    Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Added value of para-aortic surgical staging compared to
    De Cuypere M; Lovinfosse P; Goffin F; Gennigens C; Rovira R; Duch J; Fastrez M; Gebhart G; Squifflet JL; Luyckx M; Charaf G; Crener K; Buxant F; Bucella D; Jouret M; Hustinx R; Kridelka F
    Eur J Surg Oncol; 2020 May; 46(5):883-887. PubMed ID: 31784203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.
    Tsai CS; Lai CH; Chang TC; Yen TC; Ng KK; Hsueh S; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):477-84. PubMed ID: 19464824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials.
    Monk BJ; Tian C; Rose PG; Lanciano R
    Gynecol Oncol; 2007 May; 105(2):427-33. PubMed ID: 17275889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group study.
    Waggoner SE; Darcy KM; Fuhrman B; Parham G; Lucci J; Monk BJ; Moore DH;
    Gynecol Oncol; 2006 Dec; 103(3):853-8. PubMed ID: 16815535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.
    Shim SH; Kim DY; Lee SJ; Kim SN; Kang SB; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Jan; 144(1):40-45. PubMed ID: 27855989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic lymph node status assessed by 18F-fluorodeoxyglucose positron emission tomography predicts low-risk group for distant recurrence in locally advanced cervical cancer: a prospective study.
    Kang S; Park JY; Lim MC; Song YJ; Park SH; Kim SK; Chung DC; Seo SS; Kim JY; Park SY
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):788-93. PubMed ID: 20452133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Pretreatment FDG-PET in Treating Cervical Cancer Patients With Enlarged Pelvic Lymph Node(s) Shown on MRI: A Phase 3 Randomized Trial With Long-Term Follow-Up.
    Lin SY; Tsai CS; Chang YC; Ng KK; Chang TC; Kao WH; Lai CH; Hong JH
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):577-85. PubMed ID: 25936817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraperitoneal para-aortic lymph node evaluation for cervical cancer via pfannenstiel incision: technique and peri-operative outcomes.
    Moore KN; Gold MA; McMeekin DS; Walker JL; Rutledge T; Zorn KK
    Gynecol Oncol; 2008 Mar; 108(3):466-71. PubMed ID: 18191994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
    Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing survival outcomes between surgical and radiographic lymph node assessment in locally advanced cervical cancer: A propensity score-matched analysis.
    Yang J; Delara R; Magrina J; Magtibay P; Yi J; Langstraat C; Robertson M; Dinh T; Butler K
    Gynecol Oncol; 2020 Feb; 156(2):320-327. PubMed ID: 31843274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
    Boughanim M; Leboulleux S; Rey A; Pham CT; Zafrani Y; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P
    J Clin Oncol; 2008 May; 26(15):2558-61. PubMed ID: 18487573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-center experience of robot-assisted laparoscopic para-aortic lymphadenectomy for staging of locally advanced cervical carcinoma.
    Fastrez M; Goffin F; Vergote I; Vandromme J; Petit P; Leunen K; Degueldre M
    Acta Obstet Gynecol Scand; 2013 Aug; 92(8):895-901. PubMed ID: 23590725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implication of retrocrural lymph node involvement revealed by (18)F-FDG PET/CT in patients with uterine cervical cancer.
    Im HJ; Yoon HJ; Lee ES; Kim TS; Kim JY; Chung JK; Kim SK; Park SY
    Nucl Med Commun; 2014 Mar; 35(3):268-75. PubMed ID: 24253568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer.
    Houvenaeghel G; Lelievre L; Rigouard AL; Buttarelli M; Jacquemier J; Viens P; Gonzague-Casabianca L
    Gynecol Oncol; 2006 Jul; 102(1):74-9. PubMed ID: 16406062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Outcome of cervical carcinoma with locoregional lymph node involvement by FDG-PET].
    Paumier A; Blanchard P; Mazeron R; Dumas I; Morice P; Lhomme C; Leboulleux S; Haie-Meder C
    Cancer Radiother; 2012 May; 16(3):183-9. PubMed ID: 22387194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
    Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
    N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis.
    Kim HS; Park NH; Wu HG; Cho JY; Chung HH; Kim JW; Song YS; Kim SH; Kang SB
    Ann Surg Oncol; 2009 Jan; 16(1):133-9. PubMed ID: 18979134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer.
    Odunsi KO; Lele S; Ghamande S; Seago P; Driscoll DL
    Eur J Gynaecol Oncol; 2001; 22(5):325-30. PubMed ID: 11766731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.